Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12617000462381
Ethics application status
Approved
Date submitted
3/03/2017
Date registered
30/03/2017
Date last updated
13/06/2019
Date data sharing statement initially provided
13/06/2019
Type of registration
Prospectively registered

Titles & IDs
Public title
IMBRACE: Can a specialised hip BRACE alleviate symptoms of hip IMpingement? A randomised controlled trial comparing a hip brace plus usual care to usual care alone.
Scientific title
IMBRACE: Can a specialised hip BRACE alleviate symptoms of hip IMpingement? A randomised controlled trial comparing a hip brace plus usual care to usual care alone.
Secondary ID [1] 291118 0
Nil known
Universal Trial Number (UTN)
U1111-1192-8636
Trial acronym
IMBRACE
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Femoroacetabular impingement (FAI) 302022 0
Acetabular labral tear 302023 0
Condition category
Condition code
Musculoskeletal 301663 301663 0 0
Other muscular and skeletal disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Participants randomly allocated into the ‘hip brace’ arm will receive their usual non-surgical care, plus will be provided with a hip brace, designed by Ossur, to wear for the six weeks of the study. The hip brace comprises an elastic strap with loading mechanism that wraps around the affected leg, and a compressive pelvic belt that wraps around the pelvis and gluteal region. Participants will attend an appointment with an orthotist or trained research assistant, during which their hip brace will be fitted in an appointment lasting appproximately one hour. Participants will be advised to wear the hip brace for approximately two hours per day in the first week of the study, approximately four hours per day in the second week, and four hours or more in the third week of the study and thereafter (there is no maximum amount of time that participants are permitted to wear the brace each day). After one week, participants will attend a follow up fitting appointment (approx. 30 mins duration), during which it will be checked that their hip brace fits well and they are wearing it correctly. Participants will be allowed to keep their hip brace following the six weeks of the study. Participants in the treatment group will also be asked via questionnaire about the additional treatments they access during the six weeks of the study. All participants in the treatment group will be referred for an EOS scan at baseline.
Intervention code [1] 297155 0
Treatment: Devices
Comparator / control treatment
Controls for the hip brace study will receive usual non-surgical care, i.e. the non-surgical treatment they would normally receive, during the six weeks of the study. Controls will be asked via questionnaire about the treatments they access during the six weeks of the study. All participants in the control group will be referred for an EOS scan at baseline.

A case-control sub-study will be carried out comparing the EOS scans from participants with FAI and/or symptomatic labral tears in this study, to EOS scans from an asymptomatic cohort in a previous study. Permission has already been obtained to use the images from this previous study. Participants in the previous study were required to have no significant degree of leg or back pain within the previous six months nor any previous spinal, hip or knee surgery, and thus are appropriate for our use as an asymptomatic comparator group.
Control group
Active

Outcomes
Primary outcome [1] 301055 0
Change in hip-specific health-related quality of life, as measured by changes in score on the international Hip Outcome Tool (iHOT-33).
Timepoint [1] 301055 0
6 weeks
Secondary outcome [1] 331602 0
Change in hip symptoms as assessed by the Copenhagen Hip and Groin Outcome Score (HAGOS).
Timepoint [1] 331602 0
6 weeks
Secondary outcome [2] 331603 0
FAI brace tolerability as reflected by QUEST survey scores (Quebec User Evaluation of Satisfaction with assistive Technology survey).
Timepoint [2] 331603 0
6 weeks
Secondary outcome [3] 331604 0
Change in hip-specific health-related quality of life, as measured by changes in score on the international Hip Outcome Tool (iHOT-33).
Timepoint [3] 331604 0
6 months, 12 months
Secondary outcome [4] 331606 0
Alpha angle, measured on EOS scan
Timepoint [4] 331606 0
Baseline
Secondary outcome [5] 333190 0
Pelvic tilt measured on EOS scans in postures of standing, sitting, and hip flexion.
Timepoint [5] 333190 0
Baseline
Secondary outcome [6] 333191 0
Leg length inequality, measured as difference between femoral plus tibial lengths between the right and left legs on EOS scans.
Timepoint [6] 333191 0
Baseline
Secondary outcome [7] 333277 0
Lateral centre edge angle, measured on EOS scan
Timepoint [7] 333277 0
Baseline
Secondary outcome [8] 333278 0
Femoral neck shaft angle, measured on EOS scan
Timepoint [8] 333278 0
Baseline
Secondary outcome [9] 333279 0
Acetabular version, measured on EOS scan
Timepoint [9] 333279 0
Baseline
Secondary outcome [10] 333280 0
Femoral version, measured on EOS scan
Timepoint [10] 333280 0
Baseline

Eligibility
Key inclusion criteria
Inclusion criteria for hip brace study:
* Age >18 years
* Symptoms of hip pain - patients may also have symptoms of clicking, catching or giving way;
* Patient has been diagnosed with symptomatic femoroacetabular impingement OR an acetabular labral tear causing hip symptoms by a study orthopaedic surgeon.
* The patient is able to give written informed consent and to participate fully in the interventions and follow-up procedures.

Inclusion criteria for asymptomatic comparator EOS scans:
* Over 18 years of age
* Willing to have EOS scan
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Evidence of pre-existing osteoarthritis, defined as Tonnis grade >1 on AP pelvic radiograph;
* Previous significant hip pathology such as Perthes’ disease, slipped upper femoral epiphysis, developmental dysplasia of the hip, or avascular necrosis;
* Previous hip injury such as acetabular fracture, hip dislocation or femoral neck fracture.
* Previous shape changing surgery (open or arthroscopic) in the affected hip, or surgery planned for within the next six weeks.

Exclusion criteria for asymptomatic comparator EOS scans:
* Significant degree of leg or back pain within the previous six months.
* Previous spinal, hip or knee surgery.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Date of first participant enrolment
Anticipated
1/04/2017
Actual
6/07/2017
Date of last participant enrolment
Anticipated
31/10/2018
Actual
31/10/2018
Date of last data collection
Anticipated
31/10/2019
Actual
Sample size
Target
62
Accrual to date
Final
38
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 7601 0
Royal North Shore Hospital - St Leonards
Recruitment postcode(s) [1] 15500 0
2065 - St Leonards

Funding & Sponsors
Funding source category [1] 295557 0
Commercial sector/Industry
Name [1] 295557 0
Ossur
Country [1] 295557 0
Iceland
Primary sponsor type
University
Name
University of Sydney
Address
University of Sydney
Camperdown
NSW 2006
Australia
Country
Australia
Secondary sponsor category [1] 294678 0
None
Name [1] 294678 0
Address [1] 294678 0
Country [1] 294678 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 296878 0
North Sydney Local Health District
Ethics committee address [1] 296878 0
Research Office
Kolling Building, Level 13
Royal North Shore Hospital
St Leonards
NSW 2065
Ethics committee country [1] 296878 0
Australia
Date submitted for ethics approval [1] 296878 0
08/08/2016
Approval date [1] 296878 0
10/10/2016
Ethics approval number [1] 296878 0
HREC/16/HAWKE/285

Summary
Brief summary
What is the study purpose?
The purpose of this study is to investigate whether a specially-designed hip brace is effective for treating hip impingement. We hypothesise that the hip brace will help alleviate hip pain for people with hip impingement.

What does the study involve?
Participation in this study goes for six weeks. This type of study is known as a ‘randomised trial’. Since we don’t yet know whether the hip brace is effective in treating hip impingement, we need to compare it to the usual treatment people receive. To do this, study participants are put into two groups: one group using the hip brace as well as the normal treatment their doctor would recommend, and the other group just having the normal treatment their doctor would recommend for hip impingement. To ensure the groups are similar to start with, a computer allocates each study participant into a group randomly, like the flip of a coin. Participants will fill out questionnaires about their hip symptoms before beginning the study, and then also fill out the questionnaires after six weeks, allowing the researchers to compare results between the two groups to see which treatment is better.

Here is some further information about each of the two treatments :

1. Treatment with the hip brace
The hip brace is a new device that has been designed by Ossur, a company that develops and manufactures non-invasive orthopaedic equipment. The brace has been made for people with hip impingement, with the purpose of reducing their hip symptoms. There has not been any previous study on the effectiveness of this hip brace for hip impingement, so we don’t yet know if it is effective or not. People allocated to receive treatment with the hip brace can still continue with the normal treatment for their hip recommended by their doctor. However they cannot have surgery during the six weeks of the study and cannot start any other new treatments that their doctor has not recommended. Participants allocated to the hip brace gorup will receive the hip brace at no cost to them, and will be free to keep the hip brace after the study is over.

2. Normal treatment
Participants allocated to receive normal treatment will be asked to simply proceed with the normal treatment that your doctor recommends for your hip impingement (apart from surgery). Participants allocated to normal treatment will not be given a hip brace to use.

All people participating in this study will go for an EOS scan (a special type of low radiation dose X-ray). This will help the researchers to measure the extent of each participant's hip impingement.
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 72310 0
Prof David Hunter
Address 72310 0
Rheumatology Department
Level 7, Royal North Shore Hospital
Pacific Highway
St Leonards
NSW 2065
Country 72310 0
Australia
Phone 72310 0
+612 9463 1887
Fax 72310 0
Email 72310 0
[email protected]
Contact person for public queries
Name 72311 0
Jillian Eyles
Address 72311 0
Rheumatology Department
Level 7, Royal North Shore Hospital
Pacific Highway
St Leonards
NSW 2065
Country 72311 0
Australia
Phone 72311 0
+612 9463 1773
Fax 72311 0
Email 72311 0
[email protected]
Contact person for scientific queries
Name 72312 0
David Hunter
Address 72312 0
Rheumatology Department
Level 7, Royal North Shore Hospital
Pacific Highway
St Leonards
NSW 2065
Country 72312 0
Australia
Phone 72312 0
+612 9463 1887
Fax 72312 0
Email 72312 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment
Individual participant data cannot be shared for this trial.


What supporting documents are/will be available?

Current supporting documents:


Updated to:
Doc. No.TypeCitationLinkEmailOther DetailsAttachment
23488Study protocol  [email protected]
23489Informed consent form  [email protected]
23490Ethical approval  [email protected]

Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseCan a Hip Brace Improve Short-Term Hip-Related Quality of Life for People With Femoroacetabular Impingement and Acetabular Labral Tears: An Exploratory Randomized Trial.2022https://dx.doi.org/10.1097/JSM.0000000000000974
N.B. These documents automatically identified may not have been verified by the study sponsor.